Annual Shareholders Equity
$60.14 M
+$1.27 M+2.17%
31 December 2023
Summary:
Leap Therapeutics annual stockholders equity is currently $60.14 million, with the most recent change of +$1.27 million (+2.17%) on 31 December 2023. During the last 3 years, it has risen by +$13.49 million (+28.92%). LPTX annual shareholders equity is now -44.26% below its all-time high of $107.89 million, reached on 31 December 2021.LPTX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$48.95 M
-$16.83 M-25.59%
30 September 2024
Summary:
Leap Therapeutics quarterly stockholders equity is currently $48.95 million, with the most recent change of -$16.83 million (-25.59%) on 30 September 2024. Over the past year, it has dropped by -$23.05 million (-32.02%). LPTX quarterly shareholders equity is now -58.09% below its all-time high of $116.82 million, reached on 30 September 2021.LPTX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LPTX Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.2% | -32.0% |
| 3 y3 years | +28.9% | -58.1% |
| 5 y5 years | +555.5% | +780.1% |
LPTX Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -44.3% | +28.9% | -58.1% | +72.8% |
| 5 y | 5 years | -44.3% | +3538.6% | -58.1% | +2899.0% |
| alltime | all time | -44.3% | +160.0% | -58.1% | +148.8% |
Leap Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $48.95 M(-25.6%) |
| June 2024 | - | $65.79 M(+38.9%) |
| Mar 2024 | - | $47.37 M(-21.2%) |
| Dec 2023 | $60.14 M(+2.2%) | $60.14 M(-16.5%) |
| Sept 2023 | - | $72.01 M(-14.3%) |
| June 2023 | - | $84.06 M(+196.7%) |
| Mar 2023 | - | $28.33 M(-51.9%) |
| Dec 2022 | $58.87 M(-45.4%) | $58.87 M(-16.0%) |
| Sept 2022 | - | $70.07 M(-15.9%) |
| June 2022 | - | $83.32 M(-15.5%) |
| Mar 2022 | - | $98.56 M(-8.6%) |
| Dec 2021 | $107.89 M(+131.3%) | $107.89 M(-7.6%) |
| Sept 2021 | - | $116.82 M(+290.9%) |
| June 2021 | - | $29.88 M(-22.1%) |
| Mar 2021 | - | $38.38 M(-17.7%) |
| Dec 2020 | $46.65 M(-2767.3%) | $46.65 M(-12.2%) |
| Sept 2020 | - | $53.14 M(-11.0%) |
| June 2020 | - | $59.73 M(+232.5%) |
| Mar 2020 | - | $17.96 M(-1127.1%) |
| Dec 2019 | -$1.75 M | -$1.75 M(-131.4%) |
| Sept 2019 | - | $5.56 M(-49.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | $10.94 M(-35.9%) |
| Mar 2019 | - | $17.06 M(+86.0%) |
| Dec 2018 | $9.18 M(-17.5%) | $9.18 M(+38.4%) |
| Sept 2018 | - | $6.63 M(-45.4%) |
| June 2018 | - | $12.13 M(-24.8%) |
| Mar 2018 | - | $16.13 M(+45.1%) |
| Dec 2017 | $11.12 M(-111.1%) | $11.12 M(-4.0%) |
| Sept 2017 | - | $11.59 M(-36.9%) |
| June 2017 | - | $18.35 M(-24.1%) |
| Mar 2017 | - | $24.17 M(-124.1%) |
| Dec 2016 | -$100.23 M(+42.6%) | -$100.23 M(-500.2%) |
| June 2016 | - | $25.05 M(-135.6%) |
| Dec 2015 | -$70.29 M(-252.1%) | -$70.29 M(-345.0%) |
| Sept 2015 | - | $28.69 M(-15.4%) |
| June 2015 | - | $33.91 M(-15.0%) |
| Mar 2015 | - | $39.90 M(-13.7%) |
| Dec 2014 | $46.21 M(+146.2%) | $46.21 M(-13.4%) |
| Sept 2014 | - | $53.38 M(+363.1%) |
| June 2014 | - | $11.53 M(-25.5%) |
| Mar 2014 | - | $15.47 M(-17.6%) |
| Dec 2013 | $18.77 M(+43.3%) | $18.77 M |
| Dec 2012 | $13.10 M | - |
FAQ
- What is Leap Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Leap Therapeutics?
- What is Leap Therapeutics annual shareholders equity year-on-year change?
- What is Leap Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Leap Therapeutics?
- What is Leap Therapeutics quarterly shareholders equity year-on-year change?
What is Leap Therapeutics annual stockholders equity?
The current annual shareholders equity of LPTX is $60.14 M
What is the all time high annual shareholders equity for Leap Therapeutics?
Leap Therapeutics all-time high annual stockholders equity is $107.89 M
What is Leap Therapeutics annual shareholders equity year-on-year change?
Over the past year, LPTX annual stockholders equity has changed by +$1.27 M (+2.17%)
What is Leap Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of LPTX is $48.95 M
What is the all time high quarterly shareholders equity for Leap Therapeutics?
Leap Therapeutics all-time high quarterly stockholders equity is $116.82 M
What is Leap Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, LPTX quarterly stockholders equity has changed by -$23.05 M (-32.02%)